Barely Significant
← all phrases

a positive trend

3,957 sentences · 3,957 papers · 20,246 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

a positive trendp = 0.0581.2× alphagold
When focusing on the dominant host, red oak ( Quercus rubra ; n = 32), no significant relationship was detected below 1 m ( ρ = 0.096, p = 0.600), but a positive trend was observed above 1 m ( ρ = 0.339, p = 0.058), suggesting a tendency for greater oviposition on taller portions of larger individuals ( Figure 3 ).
a positive trendp = 0.05851.2× alphagold
Regarding inflammation‐related genes, IL‐6 expression was significantly lower in the FEHC group compared to the FCD group ( p = 0.0363; Figure 7A ), while IGF‐1 expression showed a positive trend in the FEHC group compared to the FCD group ( p = 0.0585; Figure 7F ).
a positive trendp = 0.0591.2× alphagold
Additionally, a positive association between miR-1-3p and TNF was identified (p = 0.031, β = 2.193), with a positive trend observed for IL-17 (p = 0.059, β = 1.932) ( Fig. 6 ). 3.7 Functional enrichment analysis To identify miRNA-target interactions and the pathways affected by the validated miRNAs, we employed the MIENTURNET tool [ 30 ].
a positive trendp = 0.0591.2× alphagold
2a ; Model 2 A: Estimate = 0.762, SE = 0.146, p < 0.001; Table 2 ) and the model with FFC as random slope revealed a positive trend for the influence of the frequency of female coalitions (Model 2B: Estimate= 0.723, SE = 0.318, p = 0.059).
Drivers of female power in bonobos.
Commun Biol · 2025 · PMC12022330
a positive trendp = 0.061.2× alphagold
The subgroup analysis suggested that the combination therapy not only provided significant improvement in PFS (HR = 0.60, 95% CI 0.39–0.90; p = 0.01), but also had a positive trend to prolong OS (HR = 0.69, 95% CI: 0.46–1.02; p = 0.06) in patients with brain metastasis (Fig. 4 A, B).
a positive trendP = 0.061.2× alphagold
In the overall population, OS was significantly improved in the toripalimab group, with 17 months in the experimental arm vs 11 months in the placebo group (HR = 0.58, 95%CI: 0.43-0.78; P = 0.0004), maintaining a positive trend in PD-L1 CPS ≥ 10 subgroup, though without reaching statistical significance (17.0 months vs 10.9 months, HR = 0.64, 95%CI: 0.40-1.03; P = 0.06)[ 26 ].